Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Thromboembolism of Vein VTE in Colorectal Cancer 1Ovarian Neoplasms 1Kidney Neoplasms 1Fatigue 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 2040Radiotherapy 1854Cisplatin 1820Carboplatin 1530Gemcitabine 1432Paclitaxel 1289Bevacizumab 1267Docetaxel 1200pembrolizumab 1196Oxaliplatin 1157Capecitabine 1140Fluorouracil 1059Dexamethasone 971Rituximab 918Nivolumab 908Magnetic Resonance Spectroscopy 858Etoposide 839Doxorubicin 823Drug Therapy 789Radiosurgery 774Irinotecan 774Cytarabine 736fludarabine 714Leucovorin 674Lenalidomide 608fludarabine phosphate 564Temozolomide 552Filgrastim 540Radiation 539Cetuximab 535

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Interventional × isoquercitrin × Clear all
NCT07303894 2026-04-16

A Study of Isoquercetin in People With Ovarian Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
90 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT02195232 2021-03-03

CATIQ

Dana-Farber Cancer Institute

Phase 2/3 Completed
64 enrolled 7 charts
GastrointestinalThoracic

Thromboembolism of Vein VTE in Colorectal Cancer

NCT02446795 2017-01-18

QUASAR

Consorzio Oncotech

Phase 1/2 Unknown
104 enrolled
Genitourinary

Carcinoma, Renal Cell, Fatigue, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡